Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine

Novavax Offers U.S. a Fourth Strong Covid-19 Vaccine

June 14, 2021
The company’s large U.S. trial found an efficacy rate of about 90 percent. But at this point, the nation is awash in other shots.

from NYT > Top Stories https://ift.tt/2So1V6V
Unknown

Share this

Related Posts

Next
« Prev Post
Previous
Next Post »
Subscribe to: Post Comments (Atom)